Your browser doesn't support javascript.
loading
[Initial presentation of lymphoblastic crisis in a pediatric chronic myelogenous leukemia patient].
Akiyama, Kosuke; Yamamoto, Shohei; Sugishita, Yumiko; Kaneko, Ryota; Okamoto, Naoko; Koganesawa, Masaya; Fujita, Sachio; Matsuno, Ryosuke; Toyama, Daisuke; Isoyama, Keiichi.
Afiliación
  • Akiyama K; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Yamamoto S; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Sugishita Y; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Kaneko R; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Okamoto N; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Koganesawa M; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Fujita S; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Matsuno R; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Toyama D; Department of Pediatrics, Showa University Fujigaoka Hospital.
  • Isoyama K; Department of Pediatrics, Showa University Fujigaoka Hospital.
Rinsho Ketsueki ; 59(1): 75-79, 2018.
Article en Ja | MEDLINE | ID: mdl-29415942
ABSTRACT
A 9-year-old girl was referred to our hospital because of facial palsy. Both physical and blood examination revealed hepatosplenomegaly and leukocytosis, respectively. A bone marrow examination demonstrated marked hypercellularity involving myeloblasts and lymphoblasts. Based on these results, we suspected mixed phenotype acute leukemia. However, her leukemic blasts expressed B-cell antigens, and a chromosomal analysis of her bone marrow cells revealed the following karyotype 46, XX, t (9;22) (q34;q11.2). All her neutrophils were positive for the breakpoint cluster region-Abelson murine leukemia viral oncogene homolog 1 fusion protein. Based on these findings, she was diagnosed with a lymphoblastic crisis of chronic myelogenous leukemia (CML). Combined chemotherapy, involving imatinib, resulted in complete molecular remission. She received cord blood transplant (CBT) during the first complete remission; she is alive and has not suffered a relapse since two years after the CBT. The sudden onset of a blastic crisis in pediatric CML is rare, and it may be difficult to distinguish such cases from de novo Ph-positive leukemia. For diagnostic purposes, it is essential to consider a patient's clinical course and blood test results.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Crisis Blástica Límite: Child / Female / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Crisis Blástica Límite: Child / Female / Humans Idioma: Ja Revista: Rinsho Ketsueki Año: 2018 Tipo del documento: Article